The synergy between pharma associations may never materialize. It may even backfire. We will elaborate on this in an upcoming post, with the real-life case of pharma disclosure in Germany. Today, we discuss how public interest has surfaced as a surprisingly powerful ally in the pharma transparency movement.  Before exploring the ‘whats’ and ‘hows’, we […]

In one of our most effective webinars this year, Wendy Derosa and Bryan Timer, both Compliance professionals at Merck USA, had useful advice for small and mid-sized pharmaceutical companies just starting out in the analytics space. Here’s what they had to say. 1. Start Small Before the emigration to a sophisticated analytics platform, it helps […]

At qordata, we’re driven by an aggressive ‘myth-busting’ mission when it comes to the Pharma Compliance/Transparency space. And one way we measure our effectiveness is by seeking participant responses during the webinars we conduct. In our most recent webinar, in which I hosted Wendy Derosa and Bryan Timer from Merck USA, the poll results suggested […]

Putting outlook toward pre-CMS submission analytics to the test, qordata conducted a poll during its webinar earlier this month. The question was: “How important are analytics for reviewing spend prior to submission?” The results were unsurprising: 63% of participants believed using analytics prior to CMS submission was “Very Important,” with another 31% saying it was […]